Improvement of Dupilumab‐Induced Psoriasiform Eruption Following a Switch to Tralokinumab
ABSTRACT Biologic therapies have transformed the management of atopic dermatitis (AD) and prurigo nodularis (PN), yet paradoxical adverse events such as dupilumab‐induced psoriasiform eruption (DPE) are increasingly recognized. We report a 48‐year‐old Japanese man with long‐standing AD and PN who de...
保存先:
| 主要な著者: | , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Wiley
2025-12-01
|
| シリーズ: | JEADV Clinical Practice |
| 主題: | |
| オンライン･アクセス: | https://doi.org/10.1002/jvc2.70163 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|